Quantcast

Latest Boston Scientific Corporation Stories

2014-09-17 00:21:05

Vercise DBS System is the First DBS System Offering Precise Neural Targeting and a 25-Year Battery Life MARLBOROUGH, Mass., Sept. 17, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received CE Mark for the Vercise(TM) Deep Brain Stimulation (DBS) System for the treatment of tremor, including the most common form of this movement disorder known as essential tremor (ET). Tremor is characterized by involuntary and rhythmic shaking, usually associated with difficulty in an...

2014-09-15 16:28:52

No Cases of Moderate or Severe Paravalvular Aortic Regurgitation at One Year MARLBOROUGH, Mass., Sept. 15, 2014 /PRNewswire/ -- New data from the Boston Scientific (NYSE: BSX) clinical trial program of the Lotus(TM) Valve System continue to demonstrate strong performance as a less invasive treatment for patients with severe aortic stenosis who are considered high risk for surgical valve replacement. Data from the REPRISE II clinical trial confirmed safety and effectiveness out to one year,...

2014-09-10 08:32:05

Data Will Focus on Areas of Significant Unmet Patient Need, Including Coronary Artery Disease and Aortic Valve Disease MARLBOROUGH, Mass., Sept. 10, 2014 /PRNewswire/ -- Beginning Saturday, Boston Scientific Corporation (NYSE: BSX) will present data that reinforce the company's commitment to advancing science for life and to developing innovative therapies in interventional cardiology. The company will share results from more than a dozen clinical studies at the 26th Transcatheter...

2014-09-03 08:33:56

MARLBOROUGH, Mass., Sept. 3, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2014 Bank of America Merrill Lynch Global Healthcare Conference on September 17, 2014 in London, England. Michael Onuscheck, senior vice president and president, Europe, and Susan Lisa, vice president, Investor Relations, will participate in a 40-minute question and answer session regarding the company beginning at approximately 10:40 a.m. GMT. About Boston...

2014-09-02 08:30:00

MARLBOROUGH, Mass., Sept. 2, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) closed on its previously announced agreement to purchase the Interventional business of Bayer AG. The acquisition enhances the ability of Boston Scientific to offer physicians and healthcare systems a more complete portfolio of solutions to treat challenging vascular conditions. The addition of the Bayer Interventional strong commercial organization and innovative technologies supports the...

2014-08-30 12:21:03

Phase II feasibility trial provides first randomized sham-controlled data using vagus nerve stimulation to treat heart failure MARLBOROUGH, Mass., Aug. 30, 2014 /PRNewswire/ -- Boston Scientific has released the primary endpoint results from its NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) clinical trial, the first and only randomized sham-controlled clinical trial investigating vagus nerve stimulation (VNS) for the treatment of heart failure patients. Faiez Zannad, M.D.,...

2014-08-29 16:24:07

Large, Prospective, Multi-National Study Examines Management of Benign Biliary Strictures with Fully Covered Self-Expanding Metal Stents after Extended Indwell MARLBOROUGH, Mass., Aug. 29, 2014 /PRNewswire/ -- A Boston Scientific Corporation (NYSE: BSX) prospective, multinational study on stent removability and preliminary long term stricture resolution of benign biliary strictures has been published in the August issue of the peer-reviewed journal, Gastroenterology. The multinational...

2014-08-25 16:27:13

MALBOROUGH, Mass., Aug. 25, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2014 Morgan Stanley Global Healthcare Conference on September 8 in New York, NY. Mike Mahoney, chief executive officer, and Dan Brennan, executive vice president and chief financial officer, will participate in a 35-minute question and answer session regarding the company beginning at approximately 9:55 a.m. ET. A live webcast of the question and answer...

2014-08-19 04:22:48

Companies Reach Agreement to Develop a New and Differentiated FFR Guidewire and Next Generation Boston Scientific Rotablator(TM) RotaWire(TM) MARLBOROUGH, Mass. and NAGOYA, Japan, Aug. 19, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) and ASAHI INTECC (Securities Code 7747, Second Section, Tokyo and Nagoya Stock Exchange) have formalized plans to develop a new, differentiated fractional flow reserve (FFR) wire. The joint project focuses on creating a device intended...

2014-08-07 12:30:17

High performance workspace design provides open, state-of-the-art office environment BOSTON, Aug. 7, 2014 /PRNewswire/ -- Margulies Perruzzi Architects (MPA), one of Boston's most innovative architectural and interior design firms, announced that it has completed the new global headquarters for Boston Scientific Corporation, a worldwide developer, manufacturer and marketer of medical solutions. MPA provided corporate architecture and interior design services for the new 110,000 SF,...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'